CMAX Clinical Research

CMAX Clinical Research operates one of Australia’s largest and most experienced early-phase clinical trial units. Since its founding in 1993, it has conducted over 600 early phase trials—including more than 100 first-in-human studies—for global pharmaceutical, biotechnology, and device companies. The facility features state-of-the-art infrastructure with up to 78 inpatient beds and leverages Australia’s efficient regulatory environment for rapid study initiation. All studies are ICH GCP compliant and meet international regulatory standards including US FDA requirements. Their participant database exceeds over 55,000 individuals for diverse recruitment.